NCT01856855View on ClinicalTrials.gov

Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions

Prostate CancerProstate AdenocarcinomaRadiation ToxicitySexual Dysfunction

Interventions

RADIATION

Stereotactic Body Radiation Therapy with Integrated Boost

SBRT with Integrated boost at 7.25 Gy and 8.00 Gy per fraction for five fractions

Trial Locations (1)

35249

Hazelrig-Salter Radiation Oncology Center, Birmingham

All Listed Sponsors

lead

John Fiveash, MD

OTHER

NCT01856855 - Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) | Biotech Hunter | Biotech Hunter